59213-02-4 Usage
Uses
Used in Organic Synthesis:
3-(3-Formyl-1H-indol-1-yl)propanoic acid is used as a building block in the synthesis of various organic compounds due to its versatile functional groups. The indole and carboxylic acid groups provide opportunities for further chemical reactions, making it a valuable intermediate in the creation of pharmaceuticals, agrochemicals, or other specialty chemicals.
Used in Pharmaceutical Industry:
3-(3-Formyl-1H-indol-1-yl)propanoic acid is used as a potential intermediate in the development of new drugs. Its structural features, including the indole and carboxylic acid groups, may contribute to the compound's biological activity, making it a candidate for further research and development in the pharmaceutical field. The formyl group's ability to act as an aldehyde may also be exploited in the synthesis of drug molecules with specific therapeutic properties.
Used in Agrochemical Industry:
3-(3-Formyl-1H-indol-1-yl)propanoic acid is used as a precursor in the synthesis of agrochemicals, such as pesticides or plant growth regulators. 3-(3-Formyl-1H-indol-1-yl)propanoic acid's functional groups can be modified to create molecules with desired biological activities, potentially leading to the development of new and more effective agrochemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 59213-02-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,2,1 and 3 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 59213-02:
(7*5)+(6*9)+(5*2)+(4*1)+(3*3)+(2*0)+(1*2)=114
114 % 10 = 4
So 59213-02-4 is a valid CAS Registry Number.
InChI:InChI=1/C12H11NO3/c14-8-9-7-13(6-5-12(15)16)11-4-2-1-3-10(9)11/h1-4,7-8H,5-6H2,(H,15,16)
59213-02-4Relevant articles and documents
PHARMACEUTICAL PREPARATIONS COMPRISING INSULIN, ZINC IONS AND A ZINC-BINDING LIGAND
-
Page/Page column 231, (2008/06/13)
Novel preparations comprising branched ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer. The preparations have a prolonged action designed for flexible injection regimes.
PHAMACEUTICAL PREPARATIONS COMPRISING INSULIN
-
Page/Page column 226, (2010/02/15)
Novel preparations comprising ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer wherein the ligand is extended by protamine that are capable of prolonging the ac-tion of insulin preparations.
Stabilised insulin compositions
-
Page/Page column 121, (2008/06/13)
The present invention provides pharmaceutical compositions comprising insulin and novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer. The resulting preparations have improved physical and chemical stability.
PHARMACEUTICAL PREPARATIONS COMPRISING ACID-STABILISED INSULIN
-
Page/Page column 227, (2010/02/08)
Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer that are capable of prolonging the action of insulin preparations are disclosed.
Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer
-
Page 75, (2010/11/30)
Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer that are capable of prolonging the action of insulin preparations are disclosed.